Old Web
English
Sign In
Acemap
>
Paper
>
MA09.07 Genomic Landscape and Clinical Outcomes With Immune Checkpoint Inhibitors in NF1-Mutant NSCLC
MA09.07 Genomic Landscape and Clinical Outcomes With Immune Checkpoint Inhibitors in NF1-Mutant NSCLC
2021
Marcelo V. Negrao
S. Schmidt
D. SuI
R. Sharaf
H. Kemp
W. Lewis
C. Bristow
G.M. Frampton
J. Lee
J. Heymach
Don L. Gibbons
Lee A. Albacker
Ferdinandos Skoulidis
Keywords:
Cancer research
Mutant
immune checkpoint inhibitors
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]